Closed petition PE1950: Ensure immunosuppressed people in Scotland can access the Evusheld antibody treatment

Background information

Immunosuppressed people are at high risk of serious illness or death.

In a similar petition to the UK Parliament, the petitioner notes:

• Lockdown and shielding has not ended for many people with blood cancer, organ transplants, and other forms of immune compromise
• Treatments like Evusheld may offer protection for immunosuppressed people, similar to the way COVID-19 vaccines protect much of the wider population.

The clinical trials for Evusheld, showed positive results and was found to reduce the risk of developing symptomatic COVID-19 by 77%. As a result Evusheld has been authorised by the Medicines and Healthcare products Regulatory Agency (MHRA).

This treatment has also been recommended for authorisation by the European Medicines Agency, with further information on the clinical trial and decision to approve Evusheld in the UK available in the BMJ.